WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007006531) METAL SALTS OF 2 ' - ( 1H-TETRAZ0L-5-YL) -1 . 1 ' -BIPHENYL-4-CARBOXALDEHYDE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/006531    International Application No.:    PCT/EP2006/006730
Publication Date: 18.01.2007 International Filing Date: 10.07.2006
IPC:
C07D 257/04 (2006.01)
Applicants: NOVARTIS AG [CH/CH]; Lichtstrasse 35, CH-4056 Basel (CH) (For All Designated States Except US).
SEDELMEIER, Gottfried [DE/DE]; (DE) (For US Only).
GRIMLER, Dominique [FR/FR]; (FR) (For US Only)
Inventors: SEDELMEIER, Gottfried; (DE).
GRIMLER, Dominique; (FR)
Agent: HILLEBRAND, Dirk; Novartis AG, Corporate Intellectual Property, CH-4002 Basel (CH)
Priority Data:
0514206.2 11.07.2005 GB
Title (EN) METAL SALTS OF 2 ' - ( 1H-TETRAZ0L-5-YL) -1 . 1 ' -BIPHENYL-4-CARBOXALDEHYDE
(FR) SELS MÉTALLIQUES DU 2'-(1H-TETRAZOL-5-YL)-1,1'-BIPHÉNYL-4-CARBOXALDÉHYDE
Abstract: front page image
(EN)The invention relates to a method or process for the manufacture of blood pressure lowering agents, such as valsartan, novel intermediates as well as process steps in said synthesis. The method or process leads via the novel intermediate salts of the formula (IA), or a tautomer thereof, wherein [Kat]n+ is a cation and n is 1, 2, 3, 4, 5 or 6.
(FR)La présente invention concerne une méthode ou un procédé de fabrication d'agents diminuant la pression artérielle, tels que le valsartan, de nouveaux intermédiaires ainsi que des étapes de ladite synthèse. La méthode ou le procédé implique les nouveaux sels intermédiaires de formule (IA), ou un tautomère desdits sels, où [Kat]n+ est un cation et n est égal à 1, 2, 3, 4, 5 ou 6.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)